Reaktionsgleichung
[F:1][C:2]1[CH:3]=[N:4][C:5]2[CH:6]=[CH:7][C:8](=[O:17])[N:9]3[CH2:13][C:12]([OH:16])([CH2:14][OH:15])[C:11]=1[C:10]=23.FC1C=NC2C=CC(=O)N3CC(=C)C=1C=23.C(N(CC)CC)C.[C:40]1([CH3:50])[CH:45]=[CH:44][C:43]([S:46](Cl)(=[O:48])=[O:47])=[CH:42][CH:41]=1.C([Sn](=O)CCCC)CCC>ClCCl.O1CCCC1.CN(C)C=O.O>[CH3:50][C:40]1[CH:45]=[CH:44][C:43]([S:46]([O:15][CH2:14][C:12]2([OH:16])[C:11]3=[C:2]([F:1])[CH:3]=[N:4][C:5]4[CH:6]=[CH:7][C:8](=[O:17])[N:9]([C:10]=43)[CH2:13]2)(=[O:48])=[O:47])=[CH:42][CH:41]=1Komponenten
Edukt 5
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 2
Versuchsvorschrift
A mixture of (4R/S)-3-fluoro-4-hydroxy-4-(hydroxymethyl)-4,5-dihydro-7H-pyrrolo[3,2,1-de]-1,5-naphthyridin-7-one (553 mg, 2.3 mmol) (racemic material, prepared from 3-fluoro-4-methylidene-4,5-dihydro-7H-pyrrolo[3,2,1-de]-1,5-naphthyridin-7-one using AD mix alpha/beta in a similar manner to Example 1(e) Method A) in dichloromethane/tetrahydrofuran/N,N-dimethylformamide (19 ml19 ml/2 ml) was treated with triethylamine (0.5 ml, 3.5 mmol), para-toluenesulphonyl chloride (446 mg, 2.3 mmol) and dibutyltin oxide (29 mg, 0.1 mmol) and stirred at room temperature overnight. Water was then added, the organic phase was separated and washed with saturated aqueous sodium bicarbonate, separated, dried over magnesium sulphate and evaporated under vacuum. The residue was chromatographed on silica eluting with 0-100% ethyl acetate in dichloromethane then 0-10% methanol in ethyl acetate affording a white solid (321 mg, 35%).
Aufarbeitung
- customthe organic phase was separated
- washwashed with saturated aqueous sodium bicarbonate
- customseparated
- dry with materialdried over magnesium sulphate
- customevaporated under vacuum
- customThe residue was chromatographed on silica eluting with 0-100% ethyl acetate in dichloromethane
Quellen und Nachweise
- ORD-Eintrag
- ord-90c35ecce929460ca5f37a3bf5782e19
- Quelldatensatz
- uspto-grants-2010_06
- Patentnummer
- US07732460B2
Verknüpfte Notizen
Wird geladen…